Skip to main content
Equibles

MARSHALL WACE, LLP

Position in IMMX — Immix Biopharma, Inc.

CIK 1318757 LONDON, X0
Back to IMMX Full portfolio

Position in IMMX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,505,500
+$3,550,963 QoQ
Shares Held
1,794,908
+9.3% QoQ
Ownership
2.51%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 109 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IMMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. IMMX ranks #46 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in IMMX

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,505,500 1,794,908
2026-03-31 $14,954,537 1,641,552
2025-12-31 $10,348,825 1,978,743
2025-09-30 $115,022 55,035